Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Citigroup Upgrades Rigel Pharmaceuticals to Buy

Citigroup Upgrades Rigel Pharmaceuticals to Buy

Citigroup analyst Yigal Nochomovitz upgrades Rigel Pharmaceuticals (NASDAQ:RIGL) from Neutral to Buy.

byBenzinga Newsdesk

December 2, 2022

1 minute read

Citigroup analyst Yigal Nochomovitz upgrades Rigel Pharmaceuticals (NASDAQ:RIGL) from Neutral to Buy.

Analyst Ratings

Breaking Down Artivion: 4 Analysts Share Their Views

By Benzinga Insights

May 7, 8:00 AM

4 analysts have expressed a variety of opinions on Artivion (NYSE:AORT) over the past quarter, offering a diverse…

AORT

Analyst Ratings

10 Analysts Have This to Say About DuPont de Nemours

By Benzinga Insights

April 10, 3:00 PM

DuPont de Nemours (NYSE:DD) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent…

Elon Musk’s ‘Dogs Rock’ Swipe At Media Sends Canine-Themed Meme Coins Soaring

By Mehab Qureshi

October 1, 11:29 PM

In a tweet on X (formerly Twitter), Elon Musk, the CEO of Tesla, once again sent Dogecoin (CRYPTO: DOGE) and other meme-related cryptocurrencies booming.

$DOGE

Bitcoin, Ethereum, Dogecoin Rise On Fed’s Mostly Bullish Tone: Analyst Sees More Consolidation For Apex Crypto

By Shivdeep Dhaliwal

January 4, 9:27 PM

Major cryptocurrencies traded higher on Wednesday evening as the global cryptocurrency market cap rose 2.05% to $822.6 billion at 7:40 p.m. ET.